Table 1 Treatment-emergent AEs.

ConditionPatient, n (%)ConditionPatient, n (%)
Nervous system disorders4 (33.3)Musculoskeletal and connective
tissue disorders
3 (25.0)
Dizziness1 (8.3)Back pain1 (8.3)
Headache3 (25.0)Bursitis1 (8.3)
Migraine1 (8.3)Pain in extremity1 (8.3)
Paresthesia1 (8.3)Respiratory, thoracic, and
mediastinal disorders
2 (16.7)
Presyncope0Cough1 (8.3)
Infections and infestations4 (33.3)Nasal congestion1 (8.3)
Upper respiratory tract infection2 (16.7)Oropharyngeal pain0
Urinary tract infection2 (16.7)Vascular disorders1 (8.3)
Skin infection1 (8.3)Hot flush1 (8.3)
Injury, poisoning, and procedural
complications
3 (25.0)Hypertension0
Accident1 (8.3)Peripheral coldness0
Arthropod bite1 (8.3)Psychiatric disorders2 (16.7)
Clavicle fracture1 (8.3)Depression1 (8.3)
Contusion0Stress1 (8.3)
General disorders and administration
site conditions
3 (25.0)Skin and subcutaneous tissue
disorders
2 (16.7)
Peripheral swelling2 (16.7)Urticaria2 (16.7)
Chest pain1 (8.3)Ear and labyrinth disorders1 (8.3)
Fatigue1 (8.3)Tinnitus1 (8.3)
Infusion site pain0Gastrointestinal disorders1 (8.3)
Investigations3 (25.0)Dyspepsia1 (8.3)
Hemoglobin decreased1 (8.3)Nausea1 (8.3)
Monocyte count decreased1 (8.3)Vomiting1 (8.3)
Neutrophil count decreased1 (8.3)